AJP - Gastrointestinal and Liver Physiology, Vol 259, Issue 4 687-G691, Copyright © 1990 by American Physiological Society

ARTICLES

Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain

D. C. Whitcomb, I. L. Taylor and S. R. Vigna
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Pancreatic polypeptide (PP) inhibits pancreatic exocrine secretion by indirect mechanisms that may be centrally mediated. The central site of action of PP that results in inhibition of pancreatic secretion has not been identified. Using autoradiography to identify 125I-PP binding to frozen sections of rat brain, we have identified saturable, high-affinity PP receptors in high concentrations in the interpenduncular nucleus, area postrema (AP), nucleus tractus solitarius, and dorsal motor nucleus of the vagus. The PP receptor differs from neuropeptide Y and peptide YY receptors in its binding specificity and location. Because PP is not produced in the brain, and the blood-brain barrier (BBB) excludes circulating peptides from most areas in the brain, we employed an in vivo radioreceptor assay to determine whether circulating PP binds to areas such as the AP that has both an incomplete BBB and a high concentration of PP receptors. 125I-PP and 131I-bovine serum albumin were infused simultaneously into rats through a peripheral vein with or without excess unlabeled PP. After 10 min, rats were killed and the brains were removed and cut into eight regions based on the autoradiographic localization of PP receptors. There was a significant (P less than 0.02) increase in saturable radiolabeled PP accumulation in the region that included the AP, demonstrating that circulating PP can bind to this area of the brain in vivo. PP is released into the circulation after a meal via mechanisms that exhibit vagal and cholinergic dependence. We speculate that PP completes a feedback loop by binding to receptors in the AP and interacting with the adjacent vagal nuclei to inhibit vagal activity.

This article has been cited by other articles:

				Y. Li, X. Wu, Y. Zhao, S. Chen, and C. Owyang Ghrelin acts on the dorsal vagal complex to stimulate pancreatic protein secretion Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1350 - G1358. [Abstract] [Full Text] [PDF]

				S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF]

				K. N. Browning, F. H. Coleman, and R. A. Travagli Effects of pancreatic polypeptide on pancreas-projecting rat dorsal motor nucleus of the vagus neurons Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G209 - G219. [Abstract] [Full Text] [PDF]

				K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF]

				G. E. Hermann, C. A. Tovar, and R. C. Rogers LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G634 - G639. [Abstract] [Full Text] [PDF]

				P. J. Larsen, C. Fledelius, L. B. Knudsen, and M. Tang-Christensen Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats Diabetes, November 1, 2001; 50(11): 2530 - 2539. [Abstract] [Full Text] [PDF]

				X. Deng, D. R. Guarita, M. R. A. Pedroso, C. Kreiss, P. G. Wood, A. F. Sved, and D. C. Whitcomb PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R645 - R653. [Abstract] [Full Text] [PDF]

				G. E. Hermann, G. S. Emch, C. A. Tovar, and R. C. Rogers c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R289 - R299. [Abstract] [Full Text] [PDF]

				G. S. Emch, G. E. Hermann, and R. C. Rogers TNF-alpha activates solitary nucleus neurons responsive to gastric distension Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G582 - G586. [Abstract] [Full Text] [PDF]

				D. A. Schober, S. L. Gackenheimer, M. L. Heiman, and D. R. Gehlert Pharmacological Characterization of 125I-1229U91 Binding to Y1 and Y4 Neuropeptide Y/Peptide YY Receptors J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 275 - 280. [Abstract] [Full Text]

				T. Voisin, M. Goumain, A.-M. Lorinet, J.-J. Maoret, and M. Laburthe Functional and Molecular Properties of the Human Recombinant Y4 Receptor: Resistance to Agonist-Promoted Desensitization J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 638 - 646. [Abstract] [Full Text]

				P. Gregor, Y. Feng, L. B. DeCarr, L. J. Cornfield, and M. L. McCaleb Molecular Characterization of a Second Mouse Pancreatic Polypeptide Receptor and Its Inactivated Human Homologue J. Biol. Chem., November 1, 1996; 271(44): 27776 - 27781. [Abstract] [Full Text] [PDF]